Exiqon
Home Search Contact Print
0 items in basket0
Sign In
 
 
Products Services Applications Resource Center Ordering About Exiqon
microRNA Research
lncRNA Research
mRNA Research
DNA Research
Custom Oligos
Other Reagents
RNA Isolation
Sequencing
Microarray Analysis
Real-time PCR
Northern Blotting
In Situ Hybridization
Functional Analysis
RNA Preparation
Sequencing
Microarray analysis
Real-time PCR
In Situ Hybridization
Antisense
RNA Preparation
Sequencing
Microarray analysis
Real-time PCR
In Situ Hybridization
Antisense
SNP Detection
Sequencing
Microarray Analysis
In Situ Hybridization
LNA Phosphoramidites
A2 Quencher
RNA Isolation Services
microRNA PCR Services
Sequencing Services
XploreRNA
microRNA ISH Services
Custom Pharma Service
Isolation
Microarray Analysis
Northern Blotting
Real-time PCR
In Situ Hybridization
Functional Analysis
SNP Detection
RNA
microRNA
RNA
DNA
microRNA
microRNA
RNA
microRNA
RNA
DNA
microRNA
RNA
DNA
microRNA Resources
mRNA and lncRNA Resources
Documents
Reading rooms
Application Stories
Technology
Oligo design tools
Movies
microRNA
Research Guide
Reading rooms
Application Stories
Bioinformatics and data analysis
What are lncRNAs?
Application Stories
Bioinformatics
Oligo modifications
LNA™
AQ-link
Order microRNA products
Order custom oligos
Distributors
Global Service Providers
General Information
Contact
News
History
Management
Board of Directors
Newsletter
Career
Sign up to Newsletter
Newsletter Back Issues
 
Reveal RNA functions in animal models - In Vivo Guidelines

Antisense so good it works in vivo

Reveal RNA functions in animal models

As we uncover the rich diversity of RNAs, elucidating their role in cellular function and disease phenotype is essential, but challenging.

Exiqon's In vivo LNA™ antisense oligonucleotides (ASOs) are a unique tool that enable loss-of-function analyses in live animals. Expertly designed LNA™ ASOs achieve long-lasting silencing of mRNA, lncRNA or microRNA to reveal their expression, targets and effects in a broad range of tissues.

This powerful approach is being used in the development of novel RNA therapeutics. Successful clinical trials* to treat Hepatitis C are testimony to the unique drug-like properties of these short antisense molecules.

*Phase II trials of LNA™ miR-122 inhibitor (Janssen et al., N Engl J Med., 2013).

In vivo LNA™ antisense oligonucleotides

  • Target any coding or non-coding RNA
  • Expert bioinformatics design service
  • In vivo grade, in mg to kg scales
  • Exceptional potency and biostability

Success with in vivo RNA function analysis


Get started with our in vivo Guidelines

Resources


Tools for your Functional Analyses
Discover what makes Exiqon's LNA™-enhanced solutions unique
See an overview

Top 5 Tips for RNA Silencing
Maximize the impact of your RNA silencing experiments with these practical tips
Get sound advice

Successfully Validate RNA Silencing
Five tips from our experts on validating your RNA silencing experiments
Read their advice

  Privacy   Sitemap   Legal